Interferon alpha 2b for treatment of conjunctival melanoma. A case report

被引：2
|
作者：
Schumacher, C. [1 ]
Heinz, C. [1 ]
Lommatzsch, P. [1 ]
Lommatzsch, A. [1 ]
Koch, J. [1 ]
机构：
[1] St Franziskus Hosp, Augenabt, D-48145 Munster, Germany
来源：
OPHTHALMOLOGE | 2013年 / 110卷 / 08期
关键词：
Administration; topical; Conjunctival pigmentation; Conjunctival neoplasms; Interferon alpha-2b; Melanoma; PRIMARY ACQUIRED MELANOSIS; TOPICAL MITOMYCIN CHEMOTHERAPY; MALIGNANT-MELANOMA; METASTASIS; EXPERIENCE; RECURRENCE; NEOPLASIA; ATYPIA;
D O I：
10.1007/s00347-012-2736-3
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
A 71-year-old female patient with a status following multiple conjunctival excisions, histopathologically confirmed conjunctival melanoma (CMM) and also multiple therapy with mitomycin C presented with progressive conjunctival pigmentation. Treatment was carried out with local interferon alpha 2b administration four or five times daily for several months. The lesion showed regression and lost pigmentation without any side effects.
引用
收藏
页码：766 / 769
页数：4
相关论文
共 50 条
  • [31] Successful management of conjunctival intraepithelial neoplasia by interferon α-2b
    Kobayashi, A
    Yoshita, T
    Uchiyama, K
    Shirao, Y
    Kitagawa, K
    Fujisawa, A
    Tseng, SCG
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2002, 46 (02) : 215 - 217
  • [32] Interferon-α-2b withdrawalPsychotic depression: case report
    Reactions Weekly, 1999, 769 (1) : 10 - 10
  • [33] Intermediate dose interferon alfa 2b (IFN alfa 2b) in adiuvant treatment for malignant melanoma
    Agostara, B.
    Savio, G.
    Calabria, C.
    Leonardi, V.
    Laudani, Agata
    Pepe, A.
    Rondello, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 59 - 60
  • [34] INTERMEDIATE DOSE INTERFERON ALFA 2B (IFN ALFA 2B) IN ADJUVANT TREATMENT OF MALIGNANT MELANOMA
    Calabria, Caterina
    Savio, Giuseppina
    Laudani, Agata
    Leonardi, Vita
    Blasi, Livio
    Stefano, Rosalba
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2004, 15 : 88 - 89
  • [35] Interferon-α-2b/ribavirinDermatitis herpetiformis: case report
    Reactions Weekly, 2004, 1013 (1) : 10 - 10
  • [36] Pilot study on interferon alpha-2b toxicity in patients with stage III melanoma.
    Nassif, E
    Sideris, L
    ANNALES DE CHIRURGIE, 1999, 53 (08): : 690 - 692
  • [37] Interferon-α-2b/ribavirinLichenoid eruption: case report
    Reactions Weekly, 2009, 1256 (1) : 19 - 19
  • [38] Interferon-α-2b/RibavirinLichen planus: case report
    Reactions Weekly, 2014, 1528 (1) : 118 - 118
  • [39] Interferon-α-2b/ribavirinAllergic reaction: case report
    Reactions Weekly, 2020, 1816 (1) : 13 - 13
  • [40] Interferon-α-2b/ribavirinNummular eczema: case report
    Reactions Weekly, 2004, 998 (1) : 12 - 13
12345